Astria Therapeutics Inc. (ATXS)
Market Closed
23 Jan, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
12. 58
0
0%
$
718.13M Market Cap
- P/E Ratio
- Div Yield
3.06M Volume
- Eps
$ 12.58
Previous Close 
Want to track ATXS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Astria Therapeutics Inc. (ATXS) Statistics
Valuation metrics
Market Cap 718.13M
Enterprise value 626.31M
Trailing P/E (ttm) -7.4
Forward P/E -
PEG ratio 0.9
Price/Sales (ttm) 1,017.18
Price/Book (mrq) 3.13
Enterprise Value/Revenue 887.12
Enterprise Value/EBITDA -6.36
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 3.56
52-Week high 13.29
Beta -
50-Day moving average -
200-Day moving average 594.7
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:6
Last split Date 20 Aug 2021
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -139.38%
Operating margin -151.44%
Operational effectiveness
Return on assets -0.36%
Return on equity -0.38%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.01
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.7
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.93
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 10.78%
Book value per share (mrq) 4.02
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
